Skip to main content
    E

    Edgewise Therapeutics Inc (EWTX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $43.68
    -2.25 (-4.90%)

    Market Cap: $5.03B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Edgewise Therapeutics Inc (EWTX) Earnings: Report Dates and Results

    Updated Nov 4, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Edgewise Therapeutics (EWTX) is expected to report earnings on Feb 24, 2027. In the quarter ended Sep 30, 2026, Edgewise Therapeutics reported EPS of $0.84, above the -$0.55 estimate. It beat the EPS estimate in 5 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    48%(11/23)
    Avg Surprise
    +11.07%
    Streak
    1 Q

    Upcoming Estimates

    Reports Feb 24, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$0.52
    Range-$0.76 - -$0.14
    15 analysts
    Revenue Consensus
    N/A
    RangeN/A
    14 analysts
    Reports May 5, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus-$0.44
    Range-$0.53 - -$0.31
    6 analysts
    EPS Revisions
    0
    2
    30d
    EPS Estimate DriftChange to current
    90d ago-$0.55+19.6%
    60d ago-$0.54+18.6%
    30d ago-$0.54+18.6%
    7d ago-$0.51+13.3%
    Current-$0.44
    Revenue Consensus
    N/A
    RangeN/A
    5 analysts

    Next Report

    EWTX has an expected report date of Feb 24, 2027.

    Earnings History

    Of the 23 quarters below that had an estimate, EWTX beat 11, missed 10 and matched 2. The widest gap in the table came in the quarter ended Sep 30, 2026, when EPS landed 252.73% above the estimate.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReported
    Sep 30, 2026$0.84-$0.55-$0.64 - $11.45+252.73%BeatN/A111 up, 4 downNov 4, 2026
    Jun 30, 2026-$0.53-$0.48-$0.58 - -$0.40-10.42%MissN/A121 up, 1 downAug 6, 2026
    Mar 31, 2026-$0.46-$0.48-$0.58 - -$0.43+4.17%BeatN/A100 up, 5 downMay 7, 2026
    Dec 31, 2025-$0.47-$0.43-$0.50 - -$0.38-9.30%MissN/A103 up, 2 downFeb 26, 2026
    Sep 30, 2025-$0.39-$0.40-$0.44 - -$0.37+2.50%BeatN/A127 up, 0 downNov 6, 2025
    Jun 30, 2025-$0.34-$0.42-$0.48 - -$0.38+19.05%BeatN/A125 up, 1 downAug 7, 2025
    Mar 31, 2025-$0.43-$0.42-$0.51 - -$0.36-2.38%MissN/A9N/AMay 8, 2025
    Dec 31, 2024-$0.42-$0.42-$0.59 - -$0.37+0.52%BeatN/A81 up, 4 downMar 3, 2025
    Sep 30, 2024-$0.36-$0.37-$0.41 - -$0.34+2.70%BeatN/A70 up, 0 downNov 7, 2024
    Jun 30, 2024-$0.34-$0.34-$0.41 - -$0.310.00%In lineN/A70 up, 0 downAug 8, 2024
    Mar 31, 2024-$0.33-$0.41-$0.49 - -$0.28+19.51%BeatN/A50 up, 0 downMay 9, 2024
    Dec 31, 2023-$0.47-$0.43-$0.50 - -$0.39-9.30%MissN/A51 up, 0 downFeb 22, 2024
    Sep 30, 2023-$0.41-$0.40-$0.48 - -$0.34-2.50%MissN/A50 up, 0 downNov 9, 2023
    Jun 30, 2023-$0.34-$0.40-$0.45 - -$0.37+15.00%BeatN/A50 up, 0 downAug 10, 2023
    Mar 31, 2023-$0.36-$0.35-$0.38 - -$0.32-2.86%MissN/A60 up, 0 downMay 11, 2023
    Dec 31, 2022-$0.31-$0.33-$0.39 - -$0.30+6.06%BeatN/A50 up, 0 downFeb 23, 2023
    Sep 30, 2022-$0.34-$0.36-$0.38 - -$0.33+5.56%BeatN/A51 up, 0 downNov 3, 2022
    Jun 30, 2022-$0.32-$0.32-$0.36 - -$0.300.00%In lineN/A50 up, 0 downAug 4, 2022
    Mar 31, 2022-$0.30-$0.28-$0.31 - -$0.26-7.14%MissN/A50 up, 0 downMay 11, 2022
    Dec 31, 2021-$0.26-$0.25-$0.31 - -$0.16-4.00%MissN/A4N/AFeb 24, 2022
    Sep 30, 2021-$0.26-$0.24-$0.24 - -$0.20-8.33%MissN/A3N/ANov 10, 2021
    Jun 30, 2021-$0.21-$0.17-$0.20 - -$0.16-23.53%MissN/A4N/AAug 9, 2021
    Mar 31, 2021-$0.14-$0.15N/A+6.67%BeatN/AN/AN/AMay 13, 2021
    Dec 31, 2020Not reportedN/AN/AN/ANot reportedN/AN/AN/AMar 26, 2021
    Last 24 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$1.63, after -$1.45 the year before. It was -$0.87 for the year ended Dec 31, 2021, the oldest of the 5 fiscal years below with reported EPS.

    Fiscal year endedEPSChange
    Dec 31, 2025-$1.63N/A
    Dec 31, 2024-$1.45N/A
    Dec 31, 2023-$1.58N/A
    Dec 31, 2022-$1.27N/A
    Dec 31, 2021-$0.87N/A
    Dec 31, 2020Not reportedN/A

    Frequently Asked Questions About EWTX

    When is Edgewise Therapeutics's next earnings date?

    Edgewise Therapeutics's next earnings report is expected for Feb 24, 2027.

    Did EWTX beat earnings estimates last quarter?

    Yes. Edgewise Therapeutics reported EPS of $0.84 for the quarter ended Sep 30, 2026, above the -$0.55 estimate, a 252.73% surprise.

    What EPS do analysts expect from EWTX next quarter?

    The consensus EPS estimate for Edgewise Therapeutics for the quarter ending Dec 31, 2026 is -$0.52 from 15 analysts, with estimates from -$0.76 to -$0.14.

    How often does EWTX beat earnings estimates?

    Edgewise Therapeutics beat the EPS estimate in 5 of the last 8 quarters, with an average surprise of +32.11%.